Alterity Therapeutics (Alterity Therapeutics) Total Assets : $0.00 Mil (As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Alterity Therapeutics Total Assets?

Alterity Therapeutics's Total Assets for the quarter that ended in Sep. 2023 was $0.00 Mil.

During the past 12 months, Alterity Therapeutics's average Total Assets Growth Rate was 76.10% per year. During the past 3 years, the average Total Assets Growth Rate was 153.20% per year. During the past 5 years, the average Total Assets Growth Rate was 27.70% per year. During the past 10 years, the average Total Assets Growth Rate was 0.90% per year.

During the past 13 years, Alterity Therapeutics's highest 3-Year average Total Assets Growth Rate was 326.40%. The lowest was -71.70%. And the median was 2.40%.

Total Assets is connected with ROA %. Alterity Therapeutics's annualized ROA % for the quarter that ended in Sep. 2023 was 0.00%. Total Assets is also linked to Revenue through Asset Turnover. Alterity Therapeutics's Asset Turnover for the quarter that ended in Sep. 2023 was 0.00.

Alterity Therapeutics Total Assets Historical Data

The historical data trend for Alterity Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterity Therapeutics Total Assets Chart

Alterity Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

Get a 7-Day Free Trial

13.83

6.84

25.68

29.07

18.33

Alterity Therapeutics Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															22.53	-	18.33	-	-

Alterity Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Alterity Therapeutics's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	15.311	+	3.023
	=	18.33

Alterity Therapeutics's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2023 )	+	Total Liabilities (Q: Sep. 2023 )
	=	N/A	+	N/A
	=	N/A

Alterity Therapeutics (NAS:ATHE) Total Assets Explanation

Total Assets is connected with ROA %.

Alterity Therapeutics's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %	=	Net Income (Q: Sep. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	0	/	( (18.334	+	0)	/ 1 )
	=	0	/	18.334
	=	0.00 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Alterity Therapeutics's Asset Turnover for the quarter that ended in Sep. 2023 is

	Asset Turnover
=	Revenue (Q: Sep. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
=	0	/	( (18.334	+	0)	/ 1 )
=	0	/	18.334
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Alterity Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Alterity Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Alterity Therapeutics (Alterity Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alterity Therapeutics Ltd (NAS:ATHE) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

PBN:Germany ATH:Australia

Address

350 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.alteritytherapeutics.com

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.